Journal
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Volume 17, Issue 8, Pages 439-441Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RHU.0b013e31823a58d7
Keywords
vasculitis; polyarteritis nodosa; hepatitis C; rituximab
Categories
Ask authors/readers for more resources
By contrast to cryoglobulinemic vasculitis, polyarteritis nodosa associated with hepatitis C virus (HCV) infection is rare and still a controversial entity. The best treatment for this condition is not established. Cases reported in the literature have been treated with various combinations of corticosteroids, antiviral therapy, and immunosuppressants. We report a case of severe life-threatening HCV-associated polyarteritis nodosa successfully treated with rituximab and a short course of corticosteroids without antiviral therapy. This case, along with recently published data, emphasizes the value of B-cellYtargeted therapy in this unusual form of HCV-associated vasculitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available